The expression of HuR and other RBPs are perturbed in several pathological conditions including human cancer, such as breast cancer, lung cancer, mesothelioma, ovarian cancer and colon cancer [5–7]. This evidence concerns the gene ELAVL1 and ovarian carcinoma.